These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 11751964)

  • 1. Dual effect of CD85/leukocyte Ig-like receptor-1/Ig-like transcript 2 and CD152 (CTLA-4) on cytokine production by antigen-stimulated human T cells.
    Saverino D; Merlo A; Bruno S; Pistoia V; Grossi CE; Ciccone E
    J Immunol; 2002 Jan; 168(1):207-15. PubMed ID: 11751964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD85/LIR-1/ILT2 and CD152 (cytotoxic T lymphocyte antigen 4) inhibitory molecules down-regulate the cytolytic activity of human CD4+ T-cell clones specific for Mycobacterium tuberculosis.
    Merlo A; Saverino D; Tenca C; Grossi CE; Bruno S; Ciccone E
    Infect Immun; 2001 Oct; 69(10):6022-9. PubMed ID: 11553539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions.
    Saverino D; Fabbi M; Ghiotto F; Merlo A; Bruno S; Zarcone D; Tenca C; Tiso M; Santoro G; Anastasi G; Cosman D; Grossi CE; Ciccone E
    J Immunol; 2000 Oct; 165(7):3742-55. PubMed ID: 11034379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTLA-4 (CD152) inhibits the specific lysis mediated by human cytolytic T lymphocytes in a clonally distributed fashion.
    Saverino D; Tenca C; Zarcone D; Merlo A; Megiovanni AM; Valle MT; Manca F; Grossi CE; Ciccone E
    J Immunol; 1999 Jan; 162(2):651-8. PubMed ID: 9916682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152).
    Griffin MD; Hong DK; Holman PO; Lee KM; Whitters MJ; O'Herrin SM; Fallarino F; Collins M; Segal DM; Gajewski TF; Kranz DM; Bluestone JA
    J Immunol; 2000 May; 164(9):4433-42. PubMed ID: 10779742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonistic roles for CTLA-4 and the mammalian target of rapamycin in the regulation of clonal anergy: enhanced cell cycle progression promotes recall antigen responsiveness.
    Vanasek TL; Khoruts A; Zell T; Mueller DL
    J Immunol; 2001 Nov; 167(10):5636-44. PubMed ID: 11698435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation.
    Vandenborre K; Van Gool SW; Kasran A; Ceuppens JL; Boogaerts MA; Vandenberghe P
    Immunology; 1999 Nov; 98(3):413-21. PubMed ID: 10583602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile.
    Broeren CP; Gray GS; Carreno BM; June CH
    J Immunol; 2000 Dec; 165(12):6908-14. PubMed ID: 11120816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of CTLA-4 signals inhibits Th2-mediated murine chronic graft-versus-host disease by an enhanced expansion of regulatory CD8+ T cells.
    Sakurai J; Ohata J; Saito K; Miyajima H; Hirano T; Kohsaka T; Enomoto S; Okumura K; Azuma M
    J Immunol; 2000 Jan; 164(2):664-9. PubMed ID: 10623808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated self-MHC-reactive T cells have the cytokine phenotype of Th3/T regulatory cell 1 T cells.
    Kitani A; Chua K; Nakamura K; Strober W
    J Immunol; 2000 Jul; 165(2):691-702. PubMed ID: 10878341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted CTLA-4 engagement induces CD4+CD25+CTLA-4high T regulatory cells with target (allo)antigen specificity.
    Vasu C; Prabhakar BS; Holterman MJ
    J Immunol; 2004 Aug; 173(4):2866-76. PubMed ID: 15295006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-15 and cognate antigen successfully expand de novo-induced human antigen-specific regulatory CD4+ T cells that require antigen-specific activation for suppression.
    Koenen HJ; Fasse E; Joosten I
    J Immunol; 2003 Dec; 171(12):6431-41. PubMed ID: 14662842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
    Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
    J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired primary immune response in type-1 diabetes. Functional impairment at the level of APCs and T-cells.
    Spatz M; Eibl N; Hink S; Wolf HM; Fischer GF; Mayr WR; Schernthaner G; Eibl MM
    Cell Immunol; 2003 Jan; 221(1):15-26. PubMed ID: 12742378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engagement of OX40 enhances antigen-specific CD4(+) T cell mobilization/memory development and humoral immunity: comparison of alphaOX-40 with alphaCTLA-4.
    Evans DE; Prell RA; Thalhofer CJ; Hurwitz AA; Weinberg AD
    J Immunol; 2001 Dec; 167(12):6804-11. PubMed ID: 11739496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R; Yssel H; de Vries JE
    J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic adenosine 5'-monophosphate and calcium induce CD152 (CTLA-4) up-regulation in resting CD4+ T lymphocytes.
    Vendetti S; Riccomi A; Sacchi A; Gatta L; Pioli C; De Magistris MT
    J Immunol; 2002 Dec; 169(11):6231-5. PubMed ID: 12444128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTLA-4 ligation blocks CD28-dependent T cell activation.
    Walunas TL; Bakker CY; Bluestone JA
    J Exp Med; 1996 Jun; 183(6):2541-50. PubMed ID: 8676075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation.
    Murphy EE; Terres G; Macatonia SE; Hsieh CS; Mattson J; Lanier L; Wysocka M; Trinchieri G; Murphy K; O'Garra A
    J Exp Med; 1994 Jul; 180(1):223-31. PubMed ID: 7516409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells.
    Krummel MF; Allison JP
    J Exp Med; 1996 Jun; 183(6):2533-40. PubMed ID: 8676074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.